Results 11 to 20 of about 2,457,946 (249)

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients [PDF]

open access: yesFrontiers in Oncology, 2013
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients
Thomas eLehrnbecher   +3 more
doaj   +2 more sources

Posaconazole in the management of refractory invasive fungal infections [PDF]

open access: yesTherapeutics and Clinical Risk Management, 2008
Stefan Langner, Philipp B Staber, Peter NeumeisterDivision of Hematology, Department of Internal Medicine, Medical University of Graz, AustriaAbstract: The rising incidence of invasive fungal infections due to the expanding population of ...
Stefan Langner   +2 more
doaj   +1 more source

Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™ [PDF]

open access: yes, 2011
Background: Despite advances in the treatment, the morbidity and mortality rate associated with invasive aspergillosis remains unacceptably high (70–90%) in immunocompromised patients.
M N V Ravi Kumar   +20 more
core   +5 more sources

Invasive fungal infections

open access: yesAfrican Journal of Thoracic and Critical Care Medicine, 2022
-
openaire   +3 more sources

Invasive Fungal Infections 2021

open access: yesJournal of Fungi, 2022
Invasive fungal infections (IFIs) represent a significant problem in a large proportion of immunocompromised individuals and critically ill patients [...]
Xess I., Pagano L., Dabas Y.
openaire   +3 more sources

Invasive Fungal Infections in Persons Living with HIV in an Amazonian Context: French Guiana, 2009–2019

open access: yesJournal of Fungi, 2021
Although the burden of histoplasmosis in patients with advanced HIV has been the focus of detailed estimations, knowledge about invasive fungal infections in patients living with HIV in an Amazonian context is somewhat scattered.
Laurène Cachera   +12 more
doaj   +1 more source

SARS-CoV-2 related ARDS and invasive fungal infections in intensive care patients

open access: yesClinical Infection in Practice, 2022
SARS-CoV-2 infection can potentially necessitate intensive care management. An increasing number of case reports are found in the literature indicating patients admitted in an intensive care setting with COVID-19 pneumonitis being complicated with ...
Darren Borg   +2 more
doaj   +1 more source

Sporothrix humicola (Ascomycota: Ophiostomatales) – A soil-borne fungus with pathogenic potential in the eastern quoll (Dasyurus viverrinus)

open access: yesMedical Mycology Case Reports, 2019
The genus Sporothrix contains both species pathogenic to humans and animals as well as environmental fungi. S. humicola, a member of the latter S. pallida clade, has previously been reported only from soil.
Anne Nesseler   +6 more
doaj   +1 more source

Evaluation of an enzyme immunoassay and immunodiffusion for detection of anti‐Histoplasma antibodies in serum from cats and dogs

open access: yesJournal of Veterinary Internal Medicine, 2023
Background Histoplasma antigen and anti‐Histoplasma antibody detection are used to support the diagnosis of histoplasmosis. There is a paucity of published data on antibody assays.
Rebecca Tims   +5 more
doaj   +1 more source

Comparison of quantitative real time PCR with Sequencing and ribosomal RNA-FISH for the identification of fungi in Formalin fixed, paraffin-embedded tissue specimens [PDF]

open access: yes, 2011
Background: Identification of the causative agents of invasive fungal infections (IFI) is critical for guiding antifungal therapy. Cultures remain negative in a substantial number of IFI cases.
Rickerts Volker   +17 more
core   +2 more sources

Home - About - Disclaimer - Privacy